What did @ceecee.1112 actually say?
CeeCee, 38, says she has been dealing with perimenopause symptoms for three years and just completed her first week on estrogen and progesterone. Her reported week-one changes include better energy, improved sleep, and being "not as moody or crabby." She's cautious about the brain fog, saying she doesn't want to "label something if I don't know 100% just yet." She also notes a follow-up with her doctor in two and a half months and encourages women in their 30s to advocate for themselves.
Her symptom history includes hot flashes, joint pain, brain fog, and depression, all of which she says went unaddressed for years. The video is personal experience content, not medical advice, but it's reaching a large audience searching for perimenopause information.
Does the science back this up?
Partially, yes. Estrogen and progesterone can produce noticeable symptom relief quickly for some women, but a single week is too short to draw firm conclusions. Sleep and mood improvements within the first week are plausible but not guaranteed by the literature.
A 2023 Menopause journal meta-analysis (Hickey et al.) found that menopausal hormone therapy significantly improved sleep quality and vasomotor symptoms, but most trials measured outcomes over 4 to 12 weeks, not seven days. For sleep, some studies do show early improvement: a 2019 RCT published in Climacteric (Joffe et al.) found sleep disruption improved within two weeks of transdermal estradiol. Mood effects are also biologically plausible early on. Estrogen modulates serotonin and dopamine pathways, and a 2018 review in the Journal of Affective Disorders (Gordon et al.) found estrogen had measurable antidepressant-adjacent effects, particularly in perimenopausal women. So the timeline isn't impossible. It's just not typical, and placebo and expectation effects are real variables here.
What did they get right?
Quite a bit, actually. CeeCee gets credit for intellectual honesty. Her caution about the brain fog, specifically saying she doesn't want to over-claim results she can't confirm yet, is exactly the right approach. That kind of self-skepticism is rare in testimonial content.
She's also correct that perimenopause can begin in the mid-to-late 30s. The average onset of perimenopause is around 47, but it can start earlier, and the SWAN cohort study (Harlow et al., 2012, Menopause) documented symptomatic perimenopause in women under 40. Her frustration about spending three years undiagnosed also reflects a documented problem. A 2022 survey published in Menopause (Faubion et al.) found that women wait an average of several years before receiving a perimenopause diagnosis, and many are initially misdiagnosed with anxiety or depression. Her advocacy message, while anecdotal, points to a real systemic gap in women's healthcare.
What did they get wrong?
The framing of week-one results as confirmation that HRT is working is premature. Not wrong exactly, but potentially misleading for viewers who might start treatment expecting the same rapid turnaround.
The biggest issue is selection bias in social media health content. Viewers only see the week-one success stories. Women who started HRT and felt worse, or who experienced side effects like bloating, breast tenderness, or mood swings during the adjustment period, are less likely to make a video. A 2021 Cochrane review (Marjoribanks et al.) noted that adverse events and discontinuation rates in HRT trials are non-trivial, with breast tenderness and irregular bleeding among the most commonly reported early side effects. None of that context appears here. The video also doesn't mention that estrogen and progesterone formulations, doses, and delivery methods vary significantly, and what worked for her may not be the right starting point for someone else.
What should you actually know?
HRT for perimenopause is a legitimate, evidence-supported treatment for a real condition that is chronically underdiagnosed in younger women. The research backing it for symptom relief, particularly vasomotor symptoms and sleep, is solid. But week-one testimonials are not clinical evidence.
A few things worth knowing before you treat this video as a template:
- Perimenopause diagnosis in women under 40 is complex. FSH, estradiol, and clinical history all factor in, and a single lab value is not enough.
- Estrogen without progesterone in women with a uterus carries endometrial cancer risk. CeeCee appears to be on combined therapy, which is the standard of care.
- HRT is not appropriate for everyone. Women with a history of certain cancers, blood clots, or cardiovascular conditions require individualized risk assessment.
- Early symptom relief in week one is possible but not the norm. Expect a trial period of 8 to 12 weeks before evaluating whether a regimen is working.
- Advocating for yourself in a medical setting is genuinely important. The research supports that women's perimenopausal symptoms are frequently dismissed or misattributed.